View Cart  

Senate BPCA, PREA Bill Bumps Up Deadlines, Grants FDA More Authority

Drugmakers would need to submit pediatric study plans to the FDA sooner in the drug development process under a bipartisan Senate bill that would make three programs intended to encourage pediatric trials of medical products permanent.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00